Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 25 Late-Breaking Discussion: The ADVANCE-HTN Trial
Author(s): Harriette Van Spall , Luke Laffin Added: 1 year ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial… View more

Prevention & Chronic Conditions
Community Approaches to Hypertension Care in Sri Lanka
Author(s): Nazneem Wahab , Neranga Samaratunge , Dulaanga Rathnayake Added: 9 months ago

Prevention & Chronic Conditions
Comparison of the Prevalence of Hypertension Using Three Proposed Criteria
Author(s): Kristina Marie Michelle O Rivera , Lucky Cuenza Added: 1 month ago

Prevention & Chronic Conditions

Guidelines & Statements
ACC 26: MOMENTUM – Hypercortisolism in Resistant Hypertension
Author(s): Deepak L Bhatt Added: 1 month ago
American College of Cardiology Congress 2026 – Dr Deepak Bhatt (Mount Sinai Fuster Heart Hospital, New York, US) joins us to discuss primary results from the MOMENTUM study (NCT06829537; Corcept Therapeutics) investigating the prevalence and clinical impact of endogenous hypercortisolism in patients with resistant hypertension.This prospective, cross-sectional observational study enrolled 1,143… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Hypertension in Asia-Pacific
Author(s): Raja Ezman Raja Shariff , Haowen Jiang , Jonathan Yap , et al Added: 1 year ago

Prevention & Chronic Conditions
New ESC Guidelines for the Management of Hypertension
Author(s): Rhian Touyz Added: 1 year ago
ESC Congress 2024 — Dr Rhian Touyz (McGill University Health Center, CA) joins us to discuss key highlights from the ESC 2024 guidelines for the management of elevated blood pressure and hypertension.The new guidelines introduce a new systolic blood pressure treatment target range of 120-129 mmHg, placing emphasis on an intensive target treatment as the first step in patient management - only… View more

Prevention & Chronic Conditions
Spironolactone versus Eplerenone for Resistant Hypertension
Author(s): Hanselim Lim , Wuri Noviar Hamdani Added: 2 years ago

Prevention & Chronic Conditions
Hypertension and Abnormal Renal Function in Type-1 EHRA Valvular AF
Author(s): Rena Winant , Sunu Budhi Raharjo , Rina Ariani , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Low-Dose Triple Pill vs Monotherapy for Hypertension
Added: 2 months ago Source:  Cardiac Failure Review
Single-pill low-dose combination (LDC) therapy is an emerging strategy for improving blood pressure (BP) control in patients with hypertension.¹ Two new phase III trials, HM-APOLLO-301 and HM-APOLLO-302, have evaluated the efficacy and safety of an ultra-low-dose triple combination pill compared with standard-dose monotherapy as an initial treatment for mild-to-moderate hypertension… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Pregnancy Outcomes in ACHD Patients in Indonesia
Author(s): Dyah Wulan Anggrahini , Detty Siti Nurdiati , Anggoro Budi Hartopo , et al Added: 6 months ago

Inherited and Congenital Cardiac Conditions

Prevention & Chronic Conditions